Cialis vs Sildenafil (Generic): What to Do When One Fails

How These Two Drugs Actually Differ

Generic sildenafil and brand-name tadalafil share the same mechanism but behave differently in the body, and those differences matter when one stops working.

Both drugs block phosphodiesterase type 5 (PDE5), the enzyme that breaks down cyclic GMP in penile smooth muscle. Blocking PDE5 prolongs smooth-muscle relaxation and allows blood to fill the corpora cavernosa in response to sexual stimulation. Neither drug produces an erection without arousal [1].

Pharmacokinetic Differences

Sildenafil reaches peak plasma concentration in 30-60 minutes and carries a half-life of 3-5 hours, so the effective window is roughly 4-6 hours. A high-fat meal delays absorption by up to 60 minutes and reduces peak concentration by 29%. Tadalafil peaks at 2 hours and has a half-life of 17.5 hours, providing a clinical window up to 36 hours. Food does not meaningfully affect tadalafil absorption [2].

Selectivity and Tissue Distribution

Tadalafil is roughly 10,000 times more selective for PDE5 over PDE6 (the retinal isoform), compared to sildenafil's approximately 1,000-fold selectivity. That difference may explain why visual side effects (blue-tinge, photophobia) appear in roughly 3% of sildenafil users and are rare with tadalafil. Tadalafil also inhibits PDE11, which may account for back pain and myalgia reported in about 6% of users [3].

Approved Dosing Ranges

Sildenafil for erectile dysfunction is approved at 25 mg, 50 mg, and 100 mg taken 30-60 minutes before activity. Generic versions are available at 20 mg (the pulmonary hypertension dose) and are commonly prescribed off-label at 20-100 mg for ED. Tadalafil is approved at 10 mg and 20 mg on-demand, or 2.5 mg and 5 mg once daily for continuous coverage [4].

What the Landmark Trials Actually Showed

The two key trials established the baseline efficacy of each drug and remain the reference point for understanding non-response.

Goldstein et al. 1998: Sildenafil's Key Trial

In the NEJM-published trial by Goldstein et al. (N=532 men with ED of broad etiology), sildenafil produced successful intercourse in 69% of attempts versus 22% on placebo. The mean International Index of Erectile Function (IIEF) erectile function domain score improved by 7.0 points from baseline. Men with diabetes showed a lower response rate of approximately 57%, and men with radical prostatectomy responded at roughly 43% [1].

Brock et al. 2002: Tadalafil's Efficacy Data

Brock et al. (J Urol 2002, N=1,112) pooled data from three randomized controlled trials of tadalafil 10 mg and 20 mg. Tadalafil 20 mg produced successful intercourse in 75% of attempts versus 32% on placebo. The IIEF erectile function domain improved by 8.6 points on tadalafil 20 mg. As with sildenafil, diabetic men responded at a lower rate, and nerve-sparing prostatectomy patients showed attenuated but measurable benefit [2].

What These Numbers Mean for Switching

Neither drug achieves 100% response. That 25-30% non-response rate in each trial is the clinical opening for a switching strategy. Critically, these trials used optimized protocols: correct timing, sexual stimulation, and full therapeutic doses. Many real-world "failures" occur under suboptimal conditions.

True Failure vs. Pseudo-Failure

The single most common reason a man thinks a PDE5 inhibitor has failed is inadequate trial conditions, not pharmacological non-response.

The Six-Attempt Standard

Current guidance from the American Urological Association (AUA) and the Sexual Medicine Society of North America (SMSNA) specifies that failure should not be declared until a man has made at least six to eight attempts at the maximum tolerated dose under conditions that include adequate sexual stimulation [5]. A prescriber who switches after two or three attempts on 50 mg sildenafil taken after a fatty dinner at the wrong time is switching prematurely.

A structured retrial framework before declaring failure should include:

• Dose: sildenafil 100 mg or tadalafil 20 mg (unless tolerability limits it)
• Timing: sildenafil taken 60 minutes before activity on an empty stomach; tadalafil taken 2 hours before
• Stimulation: physical or audiovisual sexual stimulation confirmed before and during the attempt
• Attempt count: minimum six separate occasions documented
• Alcohol: no more than two standard drinks per attempt
• Nitrate check: confirm no nitrate use in the preceding 24 hours (48 hours for longer-acting nitrates)

Men who fail this structured retrial are genuine pharmacological non-responders and are appropriate candidates for cross-drug switching.

Psychological and Relationship Factors

Performance anxiety can blunt response to any PDE5 inhibitor. The AUA recommends concurrent psychosexual counseling in men whose failure appears context-dependent, such as those with normal nocturnal tumescence but poor on-demand response [5]. Addressing anxiety does not require abandoning the medication.

Switching from Sildenafil to Tadalafil

A structured cross-over carries a meaningful success rate even in confirmed sildenafil non-responders.

Evidence for Cross-Over Response

Residual response rates after switching from sildenafil to tadalafil range from 40% to 68% in published series. A notable study in men who failed sildenafil 100 mg found that 56% achieved satisfactory intercourse after switching to tadalafil 20 mg and completing a formal six-attempt retrial [6]. The proposed mechanisms include tadalafil's longer duration (removing the timing pressure that trips up many men), its stability in the presence of food, and modest differences in PDE5 isoform binding kinetics.

On-Demand vs. Daily Tadalafil After Sildenafil Failure

After sildenafil failure, a prescriber can choose tadalafil 20 mg on-demand or tadalafil 5 mg once daily. The daily option provides continuous low-level PDE5 inhibition, which removes the pharmacokinetic timing constraint entirely. A 12-week course of daily tadalafil 5 mg has been shown to improve endothelial function markers in men with ED and type 2 diabetes, a population notoriously resistant to on-demand PDE5 therapy [7]. For men whose sildenafil failure may have a timing or anxiety component, daily dosing is a reasonable first cross-over strategy.

Practical Starting Dose After Sildenafil Failure

Start tadalafil at 10 mg on-demand and escalate to 20 mg after the first or second attempt if the response is insufficient. If switching to daily dosing, begin at 2.5 mg and titrate to 5 mg after two weeks if well-tolerated. Document the attempt log before concluding the new agent has also failed.

Switching from Tadalafil to Sildenafil

Moving from tadalafil to sildenafil is less commonly studied but follows the same logic in reverse.

When Tadalafil Fails First

Tadalafil failure at 20 mg on-demand after eight adequately conducted attempts warrants a retrial on sildenafil 100 mg. Men who find tadalafil's 36-hour window convenient but experience back pain or myalgia (reported by up to 6% of tadalafil users) may specifically prefer sildenafil's shorter duration and cleaner PDE11 profile [3].

Timing and Food Rules Are Critical Here

Sildenafil's sensitivity to food absorption is the most common setup for failure in men switching from tadalafil, who are accustomed to timing flexibility. The prescriber should explicitly counsel: take sildenafil 100 mg on an empty stomach, wait at least 45-60 minutes before any sexual activity, and plan the activity window to end within 4-5 hours of the dose. Missing any one of these steps can reduce plasma concentration enough to undermine response.

Published Response Rates

Cross-over data going the other direction (tadalafil to sildenafil) are more limited. One retrospective analysis found a 49% satisfactory response rate in men who had failed optimized tadalafil 20 mg and switched to sildenafil 100 mg [6]. That figure is lower than the tadalafil-after-sildenafil rate, which may reflect that tadalafil's pharmacokinetic advantages (food-independence, long window) already remove the most correctable confounders.

Populations Where the Drug Choice Matters More

Certain clinical subgroups show differential response rates between the two drugs and warrant specific dosing guidance.

Men with Diabetes

Diabetic men show reduced response to both agents due to autonomic neuropathy, endothelial dysfunction, and low nitric oxide bioavailability. Goldstein et al. Reported a 57% success rate in diabetic men on sildenafil [1], while pooled data suggest comparable or slightly higher rates with tadalafil 20 mg. Daily tadalafil 5 mg may provide additive benefit in this group through its endothelial effects [7]. The ADA position is that PDE5 inhibitors are first-line for ED in men with type 2 diabetes, with dose escalation to maximum tolerated dose before considering vacuum erection devices or intracavernosal injection [8].

Post-Prostatectomy Men

Nerve-sparing radical prostatectomy leaves many men with cavernous nerve injury. Response rates to on-demand sildenafil in this group range from 35% to 75% depending on nerve-sparing quality. Early post-operative penile rehabilitation with daily tadalafil 5 mg has been studied as a strategy to preserve cavernous smooth-muscle oxygenation, though a 2014 Cochrane review found insufficient evidence to recommend it universally [9]. Prescribers should wait 3-6 months after surgery before concluding that PDE5 inhibitors are ineffective, as nerve regeneration continues over that interval.

Men on Antidepressants

SSRIs and SNRIs are independent contributors to ED and ejaculatory delay. Sildenafil has shown benefit in SSRI-induced sexual dysfunction in small trials. Because tadalafil's long half-life complicates drug interaction assessment, some clinicians prefer sildenafil in men on multiple serotonergic agents, though no head-to-head trial directly addresses this preference.

Older Men (Age 65+)

Renal and hepatic clearance declines with age. The FDA label for sildenafil recommends starting at 25 mg in men over 65 due to higher plasma concentrations at standard doses [4]. Tadalafil's daily 5 mg dose does not require routine dose reduction for age alone, though renal impairment (creatinine clearance <30 mL/min) calls for a maximum of 5 mg on-demand and no more than once every 48 hours [3].

Safety Considerations That Do Not Change With Switching

Whether the drug is tadalafil or sildenafil, several absolute contraindications and interactions apply uniformly.

Nitrate Contraindication

Both drugs are absolutely contraindicated with any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) because the combination produces additive and potentially severe hypotension. The contraindication holds regardless of the nitrate route (sublingual, oral, patch, spray) and regardless of the dose of either drug [4]. This does not change on a drug switch.

Alpha-Blocker Interaction

Concurrent alpha-blockers (tamsulosin, doxazosin) require caution with both drugs. Tadalafil 5 mg once daily has been specifically studied with tamsulosin 0.4 mg and is approved for co-administration in men with both ED and benign prostatic hyperplasia. Sildenafil 25 mg is typically the starting dose when an alpha-blocker is already on board [4].

Cardiovascular Risk Assessment Before Any PDE5 Prescription

The Princeton Consensus Panel III recommends stratifying cardiovascular risk before initiating or switching PDE5 inhibitors. Men with unstable angina, recent myocardial infarction (within 90 days), uncontrolled hypertension (systolic >170 mmHg), or NYHA Class III-IV heart failure are in the high-risk group and should not receive these agents until cardiac status is stabilized [10].

When to Move Beyond PDE5 Inhibitors

Genuine failure of both agents, confirmed by structured retrial at maximum doses, calls for escalation rather than re-prescribing.

Second-Line Options

Intracavernosal injection therapy with alprostadil (prostaglandin E1) at 5-40 mcg achieves erections sufficient for intercourse in over 85% of men, including those who have failed two PDE5 inhibitors [5]. Intraurethral alprostadil (MUSE) is less effective but avoids injection. Both options require in-office training before self-administration.

Vacuum Erection Devices

Vacuum erection devices produce engorgement in a high proportion of men independent of the neurological or vascular cause of ED. Patient satisfaction is lower than with injections or PDE5 inhibitors due to the mechanical process, but the devices carry no drug interactions and are appropriate for men on nitrates who cannot use PDE5 inhibitors [5].

Penile Prosthesis

Surgical implantation of an inflatable penile prosthesis carries a satisfaction rate above 90% in appropriately selected men and is considered when both pharmacological and mechanical non-surgical options have failed [5]. The decision requires urology referral and should come only after documented failure of at least one second-line agent.

Drug Cost and Practical Prescribing Notes

Generic sildenafil 20 mg tablets are widely available at under $1 per tablet, making sildenafil the lowest-cost PDE5 option. A 100 mg dose requires four 20 mg tablets, which is still typically less expensive than branded 50 mg or 100 mg sildenafil tablets. Generic tadalafil has become widely available since 2018, with 5 mg daily and 20 mg on-demand options at significant discounts to the Cialis brand. Telehealth platforms including HealthRX can prescribe either agent following a structured clinical intake and asynchronous or synchronous consultation.